Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Rivera, Chantal A ^a,b   Gaskin, LaTausha ^a   Allman, Monique ^a   Pang, Jia ^a   Brady, Kristen ^a   Adegboyega, Patrick ^a   Pruitt, Kevin ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHOLINE; COCONUT OIL; COLLAGEN TYPE 1; INTERLEUKIN 10; MESSENGER RNA; METHIONINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; EDIBLE OIL; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FAT INTAKE; INFLAMMATION; LIVER CELL DAMAGE; LIVER NECROSIS; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; WILD TYPE; ANIMAL; C57BL MOUSE; DISEASE MODEL; FATTY LIVER; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; VITAMIN DEFICIENCY;

ANIMALS; CHOLINE DEFICIENCY; COLLAGEN TYPE I; DIETARY FATS; DIETARY FATS, UNSATURATED; DISEASE MODELS, ANIMAL; FATTY LIVER; MALE; METHIONINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR GAMMA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952688386     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-52     Document Type: Article

References (31)

1. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 2007, 22:293-303. 10.1111/j.1440-1746.2007.04824.x, 17295757.
2. Dall TM, Fulgoni VL, Zhang Y, Reimers KJ, Packard PT, Astwood JD. Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet. Am J Health Promot 2009, 23:412-422. 10.4278/ajhp.080930-QUAN-226, 19601481.
3. Lopez S, Bermudez B, Pacheco YM, Villar J, Abia R, Muriana FJ. Distinctive postprandial modulation of {beta} cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr 2008, 88:638-644.
4. Lichtenstein AH, Kennedy E, Barrier P, Danford D, Ernst ND, Grundy SM, Leveille GA, Van HL, Williams CL, Booth SL. Dietary fat consumption and health. Nutr Rev 1998, 56:S3-19.
5. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 2008, 28:1982-1988. 10.1161/ATVBAHA.108.169722, 2577575, 18772497.
6. West NA, Hamman RF, Mayer-Davis EJ, D'Agostino RB, Marcovina SM, Liese AD, Zeitler PS, Daniels SR, Dabelea D. Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care 2009, 32:175-180. 10.2337/dc08-1442, 2606809, 18945923.
7. Musso G, Gambino R, De MF, Cassader M, Rizzetto M, Durazzo M, Faga E, Silli B, Pagano G. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatol 2003, 37:909-916.
8. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003, 44:479-486. 10.1194/jlr.M200361-JLR200, 12562875.
9. Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005, 67:867-874. 10.1111/j.1523-1755.2005.00151.x, 15698426.
10. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003, 278:37041-37051. 10.1074/jbc.M305213200, 12865424.
11. Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 2005, 174:5390-5397.
12. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 2005, 126:121-129. 10.1016/j.jss.2004.12.023, 15916985.
13. Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F. Activation of NF-{kappa}B by Palmitate in Endothelial Cells: A Key Role for NADPH Oxidase-Derived Superoxide in Response to TLR4 Activation. Arterioscler Thromb Vasc Biol 2009, 29:1370-1375. 10.1161/ATVBAHA.109.188813, 19542021.
14. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007, 47:571-579. 10.1016/j.jhep.2007.04.019, 2094119, 17644211.
15. Takeuchi O, Sato S, horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002, 169:10-14.
16. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, Beutler B. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527. 10.1038/nature03253, 15690042.
17. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatol 2004, 40:386-393.
18. Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall PL. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol 2003, 18:1272-1282. 10.1046/j.1440-1746.2003.03198.x, 14535984.
19. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 2004, 287:G1035-G1043. 10.1152/ajpgi.00199.2004, 15256362.
20. Rivera CA, Abrams SH, Tcharmtchi MH, Allman M, Ziba TT, Finegold MJ, Smith CW. Feeding a corn oil/sucrose-enriched diet enhances steatohepatitis in sedentary rats. Am J Physiol Gastrointest Liver Physiol 2006, 290:G386-G393. 10.1152/ajpgi.00229.2005, 16223947.
21. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995, 75:71B-74B. 10.1016/0002-9149(95)80017-M, 7863979.
22. Keogh JB, Grieger JA, Noakes M, Clifton PM. Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 2005, 25:1274-1279. 10.1161/01.ATV.0000163185.28245.a1, 15774905.
23. Nanji AA, French SW. Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci 1989, 44:223-227. 10.1016/0024-3205(89)90599-7, 2915600.
24. Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 1989, 13:15-19. 10.1111/j.1530-0277.1989.tb00276.x, 2646971.
25. Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, Tahan SR, Dannenberg AJ. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatol 1997, 26:1538-1545.
26. Nanji AA, French SW. Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res 1986, 10:271-273. 10.1111/j.1530-0277.1986.tb05088.x, 3526949.
27. You M, Considine RV, Leone TC, Kelly DP, Crabb DW. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatol 2005, 42:568-577.
28. Szabo G, Velayudham A, Romics L, Mandrekar P. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res 2005, 29:140S-145S. 10.1097/01.alc.0000189287.83544.33, 16344599.
29. Brun P, Castagliuolo I, Di LV, Buda A, Pinzani M, Palu' G, Martines D. Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2006, 22:293-303.
30. Abergel A, Sapin V, Dif N, Chassard C, Darcha C, Marcand-Sauvant J, Gaillard-Martinie B, Rock E, Dechelotte P, Sauvant P. Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1. Dig Dis Sci 2006, 51:986-995. 10.1007/s10620-005-9031-y, 16642426.
31. Allman M, Gaskin L, Rivera CA. CCl4-induced hepatic injury in mice fed a wstern diet is associated with blunted healing. J Gastroenterol Hepatol 2010, 25:635-643. 10.1111/j.1440-1746.2009.06112.x, 20370733.